Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of PKC-iota inhibitors for the treatment of glioma

Use of PKC-iota inhibitors for the treatment of glioma

US Patent 8716266 · Granted May 6, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Memory manipulation via modification of protein kinase C zeta activity2022
Method of treating colorectal cancers using a PKC inhibitor2022
Mirror2022
Method of treating melanoma using an inhibitor of an atypical protein kinase C2021
Method of treating melanoma using an inhibitor of an atypical protein kinase C2021
Use of PKC-iota inhibitors for the treatment of breast cancer2016
Method of treating ovarian cancer using a PKC inhibitor2016
Prostate carcinogenesis predictor2015
Prostate carcinogenesis predictor2013
Method of selectively inhibiting PKCiota2013
Detection of PKC-iota as a biomarker for brain tumorigenesis2009